THE LEVEL OF VITAMIN D, ADIPONECTIN, RENAL FUNCTIONS AND LIPID PROFILE IN A SAMPLE OF TYPE 2DIABETIC PATIENTS
Abstract
Vitamin D and adiponectin were low in DM patients, Vitamin D decresed with age, while adiponectin level increased with age. The BMI was increased in patients than control. Kidney function test in patients were more than control except uric. Lipid profile serum in patients increased than control except HDL was in patients group less than control group.
References
1. Abbas, M. A. (2017). Physiological functions of Vitamin D in adipose tissue. The Journal of Steroid Biochemistry and Molecular Biology, 165, 369–381.
2. Lau, W. L., & Vaziri, N. D. (2017). Urea, a true uremic toxin: the empire strikes back. Clinical Science, 131(1), 3–12.
3. LeFevre, M. L. (2015). Screening for vitamin D deficiency in adults: US Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 162(2), 133–140.
4. Legro, R. S. (2017). Effects of obesity treatment on female reproduction: results do not match expectations. Fertility and Sterility, 107(4), 860–867.
5. Leitner, D. R., Frühbeck, G., Yumuk, V., Schindler, K., Micic, D., Woodward, E., & Toplak, H. (2017). Obesity and type 2 diabetes: Two diseases with a need for combined treatment strategies-EASO can lead the way. Obesity Facts, 10(5), 483–492.
6. Li, X., Liu, Y., Zheng, Y., Wang, P., & Zhang, Y. (2018). The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Nutrients, 10(3), 375.
7. Lin, H.-Y., Weng, S.-W., Shen, F.-C., Chang, Y.-H., Lian, W.-S., Hsieh, C.-H., Chuang, J.-H., Lin, T.-K., Liou, C.-W., & Chang, C.-S. (2020). Abrogation of toll-like receptor 4 mitigates obesity-induced oxidative stress, proinflammation, and insulin resistance through metabolic reprogramming of mitochondria in adipose tissue. Antioxidants & Redox Signaling, 33(2), 66–86.
8. Lozanov, L. B., Gorcheva, D., Lozanov, B. S., Argirova, R., Koleva, V., Kostova, B., Borisov, R. P., & Nedeva, M. (2017). Role of thyroid deficiency on adiponectin, leptin, and metabolic status in visceral obesity: a cross-sectional study. Hormone and Metabolic Research, 49(09), 667–672.
9. Lips, P., Eekhoff, M., van Schoor, N., Oosterwerff, M., de Jongh, R., Krul-Poel, Y., & Simsek, S. (2017). Vitamin D and type 2 diabetes. The Journal of Steroid Biochemistry and
10. Level of obesity is directly associated with the clinical and functional consequences of knee osteoarthritis. Scientific Reports, 10(1), 1–7.
11. Reilly, S. M., & Saltiel, A. R. (2017). Adapting to obesity with adipose tissue inflammation. Nature Reviews Endocrinology, 13(11), 633.
12. Röder, P. V, Wu, B., Liu, Y., & Han, W. (2016). Pancreatic regulation of glucose homeostasis. Experimental & Molecular Medicine, 48(3), e219–e219.
13. Rodríguez-Cubillo, B., Carnero-Alcázar, M., Cobiella-Carnicer, J., Rodríguez-Moreno, A., Alswies, A., Velo-Plaza, M., Pérez-Camargo, D., Sánchez Fructuoso, A., & Maroto-Castellanos, L. (2019). Impact of postoperative acute kidney failure in long-term survival after heart valve surgery. Interactive Cardiovascular and Thoracic Surgery, 29(1), 35–42.
14. Roseland, J. M., Phillips, K. M., Patterson, K. Y., Pehrsson, P. R., & Taylor, C. L. (2018). Vitamin D in foods: An evolution of knowledge. In Vitamin D (pp. 41–77). Elsevier.
15. Rosen, C. J., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., & Kovacs, C. S. (2012). IOM committee members respond to Endocrine Society vitamin D guideline. The Journal of Clinical Endocrinology & Metabolism, 97(4), 1146–1152.
16. Rosini, N., Cunha, H. P., Rosini, R. D., Machado, M. J., & Silva, E. L. da. (2018). Serum uric acid in children and adolescents. Jornal Brasileiro de Patologia e Medicina Laboratorial, 54(1), 21–27.
17. Ryan, D. H., & Yockey, S. R. (2017). Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over. Current Obesity Reports, 6(2), 187–194.
18. Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., & Ogurtsova, K. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Research and Clinical Practice, 157, 107843.
19. Safford, M. M., Gamboa, C. M., Durant, R. W., Brown, T. M., Glasser, S. P., Shikany, J. M., Zweifler, R. M., Howard, G., & Muntner, P. (2015). Race–Sex Differences in the Management of Hyperlipidemia: The REasons for Geographic And Racial Differences in Stroke Study. American Journal of Preventive Medicine, 48(5), 520–527.
20. Salazar, J. H. (2014). Overview of urea and creatinine. Laboratory Medicine, 45(1), e19–e20.
21. Sawhney, S., & Fraser, S. D. (2017). Epidemiology of AKI: utilizing large databases to determine the burden of AKI. Advances in Chronic Kidney Disease, 24(4), 194–204.
22. Schroeder, N., Rushovich, B., Bartlett, E., Sharma, S., Gittelsohn, J., & Caballero, B. (2015). Early obesity prevention: A randomized trial of a practice-based intervention in 0–24-month infants. Journal of Obesity, 2015.
23. Scragg, R. K. R., Stewart, A. W., McKenzie, R. L., Reeder, A. I., Liley, J. Ben, & Allen, M. W. (2017). Sun exposure and 25-hydroxyvitamin D 3 levels in a community sample: Quantifying the association with electronic dosimeters. Journal of Exposure Science & Environmental Epidemiology, 27(5), 471–477.
24. Seki, S., Oki, Y., Tsunoda, S., Takemoto, T., Koyama, T., & Yoshimura, M. (2016). Impact of alcohol intake on the relationships of uric acid with blood pressure and cardiac hypertrophy in essential hypertension. Journal of Cardiology, 68(5), 447–454.
25. Sempos, C T, & Binkley, N. (2020). 25-Hydroxyvitamin D assay standardisation and vitamin D guidelines paralysis. Public Health Nutrition, 23(7), 1153–1164.
